Regulatory Issues

The MMS monitors state and federal regulations affecting physician interaction with patients, other health care workers, hospitals, health plans and new technologies.

• BORIM Revisions of 243 CMR 2.00 August 12, 2019
• Comments Regarding Proposed Regulatory Changes to “Standards for Prescription Format and Security in Massachusetts” (105 Cmr 721.000) Regulations June 27, 2019
• Massachusetts Medical Society Opioid Therapy and Physician Communication Guidelines August 31, 2017
• Comments Regarding Proposed Regulatory Changes to Licensing and the Practice of Medicine (243 CMR 2.00) Regulations before the Board of Registration in Medicine May 19, 2017
• Testimony In Opposition to Proposed Changes to Regulations of the Executive Office of Health and Human Services, 101 CMR 317.00 May 12, 2017
• Testimony in Opposition to Proposed Changes to Masshealth Regulations, 130 CMR 433.000 May 12, 2017
• MMS Comments to CMS on Meaningful Use Stage III and MACRA December 14, 2015